This site is updated Hourly Every Day

Trending Featured Popular Today, Right Now

Colorado's Only Reliable Source for Daily News @ Marijuana, Psychedelics & more...

Post: Synthetic THC May Calm Agitation in Alzheimer’s Patients

Picture of Anschutz Medical Campus

Anschutz Medical Campus

AnschutzMedicalCampus.com is an independent website not associated or affiliated with CU Anschutz Medical Campus, CU, or Fitzsimons innovation campus.

Recent Posts

Anschutz Medical Campus

Synthetic THC May Calm Agitation in Alzheimer's Patients
Facebook
X
LinkedIn
WhatsApp
Telegram
Threads
Email

Parkinson and Alzheimer female senior elderly patient with caregiver in hospice care. Doctor hand with stethoscope check up older woman people. Old aging person seeing medical physician in hospital. Key Takeaways

Synthetic THC — the psychoactive compound in cannabis — eased anxiety in people with Alzheimer’s disease

Stressed-out caregivers also benefited, researchers report

4 in 10 people with Alzheimer’s become agitated, often leading to a search for long-term care

MONDAY, Sept. 30, 2024 (HealthDay News) — A synthetic form of the active ingredient in cannabis helps reduce agitation in people with Alzheimer’s , new research shows.

Synthetic THC (dronabinol) also gave patients’ caregivers a boost, according to findings presented Thursday at a meeting of the International Psychogeriatrics Association in Buenos Aires.

The findings may provide encouragement for the families of the 7 million Americans who have Alzheimer’s or another form of dementia. Nine out of 10 develop behavior problems, and agitation is the most common, affecting 4 in 10.

Agitated patients with Alzheimer’s often pace, wander, yell, scream and get verbally abusive. Their behavior may also leave their caregivers burned out and depressed.

"It is the agitation, not the memory loss, that often drives individuals with dementia to the emergency department and long-term care facilities," said study co-author Dr. Brent Forester , director of behavioral health for Tufts Medicine in Boston. "Dronabinol has the potential to both reduce health care costs and make an important, positive impact on caregivers’ mental and physical health."The new study included 75 outpatients with Alzheimer’s dementia. For three weeks, they took either 5 milligrams (mg) of dronabinol twice a day or a dummy pill.Symptoms of agitation were significantly improved in the patients who took dronabinol, and researchers said the drug was well-tolerated. Sign Up for Newsletters Email* Select Newsletters to Sign Up For News Updates Breaking News Sports Digest Obituaries and Death Notices "Dronabinol appears to perform just as well, if not better, than the only other FDA-approved drug for agitation in this patient population currently on the market," Forester said.A pilot study had suggested that cannabinoid therapies might […]

Leave a Reply

Your email address will not be published. Required fields are marked *

You Might Be Interested...